Who We Are Our Products Our Services Our Capabilities Careers News & Insights Contact LinkedIn Youtube Search search Menu Home News A new ENT device: UniSpray A new ENT device: UniSpray 27/10/2021 Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration. Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with promising advantages that nasal route could offer, Nemera is thrilled to extend its portfolio by launching its unidose system, UniSpray, for systemic-acting drug administration to face emergency and crisis. Other than treating conditions locally, nasal delivery is an attractive option to also administer systemic therapies which may vary from benign to serious health conditions. What’s more, is that the nasal route is not invasive and does not require healthcare professionals’ intervention where patients can self-administer their remedy with a rapid onset. UniSpray is a ready-to-use primeless device with single-metered liquid dose delivery. It offers one-handed activation with 360° functionality to face emergency and crisis. Thanks to its ergonomic design, it is intuitive and easy-to-use. UniSpray is a unidose system concept under development, designed to be robust and compatible with existing marketed primary containers. Through usability analysis and Freedom to Operate assessment, we assure reliability and regulatory compliance of our unidose concept. UniSpray at a glance: BENEFITS Intuitive and robust device with ergonomic finger rest, and broad labeling surface Safe and secured with no risk of accidental activation Accelerates time-to-market thanks to possible adaptations to conventional filling lines Equivalent utilizationas originators In-vitro Bioequivalence services proposed with the device KEY FEATURES Ready-to-use, primeless device, 360° functionality Compatible with existing primary drug container Single dose liquid delivery device with One accurate 100µL dose Compliant to regulatory exigence Freedom to Operate (FTO) Customization possibilities For new and repurposed drug To download the press release : HERE About Nemera As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission. For more information, visit www.nemera.net Share this article: Facebook Twitter LinkedIn Latest News 2021 Our news Parenteral PR Symbioze won the Pharmapack Award 2021 12/10/2021 We delighted to be the winner of the Pharmapack award with our novel device SYMBIOZE Continue Reading 2021 Inhalation Our news PR Nemera joins IPAC-RS as an Associate Member 20/10/2021 Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Continue Reading 2021 Press article Focus on injectables in the ‘Pharmaceutical Post’ 23/11/2021 Severine Duband, our Marketing Director was interviewed by the journalist of the 'Pharmaceutical Post', to talk about Symbioze and how we developed the product. The main challenge for manufacturers is... Continue Reading 2021 Our news PR Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients 16/11/2021 Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients.Following the dynamic growth of the drug delivery devices market, as a... Continue Reading See All News Get in touch Get in touch to find out more about us, our solutions and what we can do for you. If you’re looking for job opportunities, please visit: Join Our Team First Name*: Last Name*: Company Name*: Job Title*: State: Country*: Please select... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao, People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe Email*: Phone: Main Interest*: Please select... Our Services Our Products Other Channel (how did you hear about us?)*: Please select... Search Engine Social Media Website Exhibitions Press Word of Mouth Third party network Other Message*: Your personal data is intended for Nemera and its subsidiaries to process your request for information. You have rights over your personal data, such as the right to access, erase and object. For more information, see our Privacy Policy. * Required fields. LinkedIn Twitter Youtube Who We Are Privacy Policy Cookies policy Legal Policy 20 Avenue de la Gare 38290 La Verpillière - France T. +33 4 74 94 06 54 © 2021 Nemera. Website developed by Illustrate Digital